It still pays to play nice at work, a new Robert Half survey confirms. Nearly half (48 percent) of workers interviewed said being courteous to others can help an employee rise through the ranks. Another 41 percent said etiquette plays at least some role in career advancement.
Robert Half also has introduced new videos illustrating some of the most egregious examples of office etiquette faux pas as part of the firm’s ongoing video series, “Don’t Let This Happen to You.” The lighthearted videos, including “The Cupcake Caper,” along with advice on avoiding common blunders, can be found at www.roberthalf.com/dont-let-this-happen-to-you.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53175-robert-half-survey-and-companion-video-series-highlight-office-etiquette
USANA Health Sciences is pleased to announce an innovative technological advancement: its U.S. patent-pending USANA InCelligence Technology™. This exclusive cell-signaling technology—now found in various USANA® products—is designed to help your body’s cells renew and protect themselves in unique and powerful ways, representing a monumental leap forward in cellular nutrition and overall wellness.*
“USANA continues to build a reputation as an innovator in the science of cellular health and nutritional supplementation,” says USANA Founder Dr. Myron Wentz. “With USANA’s InCelligence Technology, we are ensuring that our company remains on the cutting-edge of nutritional supplementation.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7736551-usana-incelligence-technology/
In a major advancement for green technology, the TCO Certified eco-label for electronics, together with display industry leader NEC, today announced the NEC MultiSync® EA222WMe computer monitor as the first to receive the TCO Certified Edge award for groundbreaking achievements in environmental design. The award is presented in recognition of NEC’s achievement in eliminating halogens, a proven hazard to human health and the environment.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/tcodevelopment/44213/
Walt Disney Records is set to release a new hologram vinyl version of the original motion picture soundtrack for Star Wars: The Force Awakens. With score conducted and composed by five-time Academy Award®-winning composer John Williams and liner notes by the film’s director, J.J. Abrams, the double LP features a 16-page booklet on 180 gram vinyl. This one-of-a-kind vinyl set, hand etched by Tristan Duke (Jack White’s Lazaretto) of Infinity Light Science, offers a 3D hologram experience featuring the Millennium Falcon on Disc 1/Side B and a TIE Fighter on Disc 2/Side B. For optimal viewing, use a direct light source or simply hold a mobile phone flashlight above the vinyl to view the holograms.
Tristan Duke founded Infinity Light Science in 2008, a research laboratory with an emphasis on laser holography, interferometry, light-field imaging, hand-drawn holography, and relativistic imaging.
The must-have vinyl album also features Direct Metal Mastering (DMM) for an optimal listening experience. Disney Music Group has joined forces with Pro-Ject Audio Systems to showcase this unique, next-level advancement in holographic vinyl technology with the Elemental turntable, a combination of minimalist design and maximum performance from the world leader in high fidelity turntables. The two brands will collaborate on co-promotions at retail, online, and radio.
To view the multimedia release go to:
http://www.multivu.com/players/English/7847351-star-wars-the-force-awakens-vinyl/
Standard Pacific Homes, one of the nation’s leaders in homebuilding quality, today announced plans to unveil Shady Oaks, a brand new collection of impressive luxury residences nestled around the natural beauty of Southlake’s oak trees, green belts and open spaces. The 10 new home designs incorporate artistry and advancement in architecture that address the changing lifestyles of today’s homeowners with an emphasis on open spaces and indoor to outdoor connectivity. Tour the stunning model home at the Grand Opening celebration Saturday and Sunday December 8 and 9 from 10 a.m. to 5 p.m.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59469-standard-pacific-homes-new-luxury-home-designs-shady-oaks-southlake-tx
Leveraging advanced skincare science inspired by the Nobel Prize-winning discovery of Aquaporins, the Artistry Hydra-V™ collection presents a new level of skincare targeting deep hydration. This comprehensive line provides up to 24-hour hydration for skin that feels soft, smooth and supple.
Whatever level of hydration skin needs, the Artistry Hydra-V™ line answers with a range of formulas that can be customized to skin type, season and climate. “Artistry Hydra-V™ products are for the younger consumer who is not yet concerned with the signs of aging but instead want skincare products to give her a beautiful, healthy complexion. This advancement in skincare technology epitomizes the Artistry® Forward Beauty platform and meets the balanced hydration needs of women younger than 35,” says Jackie Nickel, Chief Marketing Officer for the Americas Region. “It’s our first collection to focus on deep hydration for all skin types.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7488157-amway-artistry-hydra-v/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Philips Respironics, a unit of Royal Philips (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, today announces a significant advancement in sleep therapy with the commercial release of a first of its kind minimal contact nasal mask – Wisp. Designed to fit more than 98% of sleep apnea patients, Wisp brings distinctive styling and patented technology for a better overall mask experience that may improve patient compliance.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62230-philips-respironics-announces-advancement-in-sleep-therapy-with-wisp
Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI), is introducing its latest advancement in oxygen therapy. SimplyGo is the only portable oxygen concentrator (POC) to offer continuous flow (up to 2 liters per minute) and pulse-dose delivery in a single device weighing 10 pounds or less. With this combination of capabilities, the SimplyGo POC helps homecare providers manage the therapy and lifestyle needs of nearly all oxygen users.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54713-philips-respironics-simplygo-portable-oxygen-concentrator
After a successful pilot program in October 2009, Cancer Treatment Centers of America (CTCA) is introducing an innovative approach to cancer treatment this July at each of its four hospitals in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. Called “Patient Empowered CareSM,” this advancement in the patient treatment delivery process offers patients an average of between two and three hours with a dedicated team of specialized oncology physicians and clinicians.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cancercenter/44523/
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
